DA-5218

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Diabete MellitusHealthy

Phase 1

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Dong-A ST Co., Ltd.Healthy

Start: 2022-07-08End: 2022-09-07Target: 90Updated: 2022-07-08

Phase 4

Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes

Not yet recruitingNCT07229534

Dong-A ST Co., Ltd.Diabete Mellitus

Start: 2025-11-30End: 2027-11-30Target: 238Updated: 2025-11-17